<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Dystonia":1,
"Laboratory":1,
"Spasmodic dysphonia":1,
"Vocal fold dystonia":1,
"Vocal fold spasms":1,
"Work-up":1,
"MMP11":1,
"PTC":3,
"metastasis":7,
"miR-125a-3p":1,
"Breast cancer":5,
"Invasion":2,
"LncRNA SNHG3":1,
"Proliferation":4,
"miR-384":1,
"isthmectomy":1,
"isthmus":1,
"isthmusectomy":1,
"low risk cancer":1,
"well-differentiated thyroid carcinoma":1,
"Akaike information criterion":1,
"aggressiveness":1,
"dynamic contrast-enhanced magnetic resonance imaging":1,
"papillary thyroid cancer":5,
"perfusion":1,
"permeability":1,
"tracer kinetic model":1,
"NR2F1-AS1":1,
"SOX12":1,
"miR-423-5p":1,
"Consensus":1,
"Head and neck neoplasms":2,
"Interobserver agreement":1,
"TI-RADS":3,
"Thyroid nodule":11,
"Ultrasonography":6,
"highly differentiated follicular carcinoma of ovary":1,
"imprint cytology":1,
"monodermal teratoma":1,
"struma ovarii":1,
"BRAFV600E mutation":1,
"lung metastasis":1,
"mebendazole":1,
"papillary thyroid carcinoma":16,
"undifferentiated anaplastic thyroid carcinoma":1,
"Nationwide study":1,
"Reference interval":1,
"Serum iodine":1,
"Thyroid function":1,
"Urine iodine":1,
"Aggressive subtype of breast cancer":1,
"CEMIP":1,
"Epigenetic inhibitor":1,
"GSKJ-4":1,
"H3K27me3":1,
"Cancer":6,
"Diagnosis":3,
"Diagnostic":1,
"Dysthyroïdie":1,
"Immunotherapy":3,
"Immunothérapie":1,
"Thyroid dysfunction":1,
"Traitement":1,
"Treatment":1,
"Non-small cell lung carcinoma":1,
"adenocarcinoma":2,
"differential diagnosis":1,
"dual-marker immunostaining":1,
"immunohistochemistry":5,
"squamous cell carcinoma":2,
"EZH2":2,
"H3K27me":1,
"NDRG2":1,
"UNC5B-AS1":1,
"ovarian cancer":1,
"Cytopathologie":1,
"Cytopathology":2,
"Cytoponction à l’aiguille fine":1,
"Fine needle aspiration":4,
"Glandes salivaires":1,
"Milan System":1,
"Salivary glands":1,
"Système de Milan":1,
"Terminologie":1,
"Terminology":1,
"PAR5":1,
"anaplastic thyroid carcinoma":1,
"long non-coding RNA":2,
"CTLA-4":1,
"PD-1":1,
"PD-L1":1,
"cancer immunotherapy":1,
"endocrine disorders":1,
"immune checkpoint inhibitors":1,
"Late effects":1,
"Screening":1,
"Subsequent malignant neoplasm":1,
"Thyroid cancer":26,
"Angiogenesis inhibitor":1,
"Lenvatinib":1,
"Pembrolizumab":1,
"Calcification":1,
"Hypoechoic area":1,
"Subacute thyroiditis":1,
"miR-34a-5p":1,
"progression":1,
"thymidine kinase 1":1,
"thyroid carcinoma":15,
"thyroid nodules":6,
"interreader concordance":1,
"SNP":1,
"caspase-3":1,
"hypocalcaemia":1,
"hypoparathyroidism":2,
"parathyroid hormone":1,
"thyroidectomy":9,
"DICER1":1,
"GABPA":1,
"carcinoma":3,
"follicular":2,
"thyroid":19,
"central lymph node dissection":1,
"solitary lateral lymph node metastasis":1,
"diagnostics":1,
"molecular oncology":1,
"DUXAP10":1,
"mTOR pathway":1,
"the Akt":1,
"Ectopic thyroid cancer":1,
"Occult thyroid cancer":1,
"Symptomatic papillary thyroid microcarcinoma":1,
"CK20":1,
"Merkel cell":1,
"TTF-1":1,
"collision":1,
"combined":1,
"adjuvant treatment":1,
"differentiated thyroid cancer":6,
"iodine-131":1,
"patient selection":1,
"thyroid neoplasms":8,
"Recurrent nerve injury":1,
"Thyroid surgery":1,
"DNASE1L2":1,
"EMT":1,
"invasion and migration":1,
"Bhutan":1,
"alcohol":1,
"betel nut":1,
"epidemiology":2,
"head and neck cancer":1,
"histopathology":1,
"hypopharyngeal cancer":1,
"laryngeal cancer":1,
"nasopharyngeal cancer":1,
"oral cancer":1,
"salivary gland neoplasm":1,
"sinonasal malignancy":1,
"tobacco":1,
"Langerhans's cell histiocytosis":1,
"Lung cancer":1,
"Metastases":2,
"Osteosarcoma":1,
"Wilms tumor":1,
"brown bear":1,
"epithelial–mesenchymal transition":1,
"active surveillance":1,
"chest CT":1,
"distant metastasis":2,
"papillary thyroid microcarcinoma":2,
"whole-body search":1,
"Autofluorescence":1,
"Near-infrared light":1,
"Parathyroid glands":1,
"Pathological accuracy":1,
"Bone metastases":1,
"Laser ablation":1,
"Mimimally invasive techniques":1,
"Radioiodine-refractory thyroid cancer":1,
"Thermal ablation therapies":1,
"cartilage":1,
"chondrosarcoma":1,
"larynx":1,
"rhabdomyoma":1,
"adenoid cystic carcinoma":1,
"case report":1,
"diagnosis and treatment":1,
"literature review":1,
"Drug–drug interaction":1,
"Paracetamol":1,
"Paracetamol glucuronide and paracetamol sulphate":1,
"Pharmacokinetics":1,
"Sorafenib":1,
"Sorafenib N-oxide":1,
"CCL1":1,
"HCC":1,
"PKM2":2,
"differentiation":1,
"ectosome":1,
"extracellular vesicle":1,
"hepatocellular carcinoma":2,
"macrophage":1,
"monocyte":1,
"sumoylation":1,
"Métastase":1,
"Radiotherapy":1,
"Radiothérapie":1,
"Thymoma":1,
"Thymome":1,
"JNK":1,
"JunD":1,
"miR-124-3p":1,
"mitogen-activated protein kinase":1,
"tumourigenesis":1,
"Benign neoplasm":1,
"Goiter":2,
"Dye":1,
"Parathyrodectomy":1,
"USDAP":1,
"USDAS":1,
"Ultrasound":6,
"Asymmetry":1,
"Image analysis":1,
"Nuclear shape":1,
"Software":1,
"Papillary":1,
"Pediatric":1,
"High dose hook":1,
"Interference":1,
"Prozone effect":1,
"Tg":1,
"Tumor marker":1,
"FNA":4,
"NIFTP":2,
"ROM":1,
"Bioinformatics method":1,
"IGHBP3":1,
"Tissue microarray":1,
"anaplastic":1,
"immune system":1,
"thyroid neoplasm":2,
"FOXN3":1,
"Migration":1,
"Papillary thyroid carcinoma (PTC)":1,
"Wnt/β-catenin pathway":2,
"ACR TI-RADS":2,
"ATA":1,
"FNA biopsy":1,
"Thyroid guidelines":2,
"Thyroid ultrasound":3,
"cytology":3,
"fine-needle aspiration":3,
"malignancy":2,
"uncertainty":1,
"PTC variant":1,
"microfollicular pattern":1,
"papillary pattern":1,
"rosette pattern":1,
"thyroid malignancy":1,
"Biological phenomena":1,
"Biopsy":1,
"Fine-needle":1,
"Image-guided biopsy":1,
"Large-core needle":1,
"Encapsulated papillary Thyroid carcinoma":1,
"Follicular variant":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Biomarker":1,
"Immune-infiltration":1,
"LAGE3":1,
"Prognosis":6,
"Tumor microenvironment":2,
"ccRCC":1,
"Surgery":1,
"Swallowing function":1,
"Tube feeding":1,
"Postsurgical hypothyroidism":1,
"Thyroid lobectomy":2,
"TIRADS":1,
"thyroid ultrasonography":1,
"mandibulectomy":1,
"marginal mandibulectomy":1,
"pattern of invasion":1,
"segmental mandibulectomy":1,
"Complete surgical resection":1,
"Parathyroid carcinomas":1,
"Primary hyperparathyroidism":1,
"lymph node dissection":1,
"pulmonary metastasectomy":1,
"video-assisted thoracoscopic surgery":1,
"Bilaterality":1,
"Multifocality":1,
"Recurrence-free survival":1,
"MALDI-MSI":1,
"Thyroid fine needle aspiration biopsy":1,
"Cervical carcinoma":1,
"Glycolysis":1,
"LDHA":1,
"STIP1":1,
"Merkel cell carcinoma":1,
"anti-programmed death ligand 1 inhibitor":1,
"avelumab":1,
"immune checkpoint inhibitor":1,
"thyroid transcription factor 1":1,
"Neuroendocrine tumors":1,
"PCSK2":1,
"primary origin":1,
"COVID-19":1,
"radioactive iodine":2,
"tyrosine kinase inhibitor":1,
"Contrast-enhanced ultrasound":1,
"contrast-enhanced computed tomography":1,
"laryngeal carcinoma":1,
"tumor staging":1,
"Sialadenitis":1,
"parotitis":1,
"radioiodine":1,
"sialendoscopy":1,
"stricture":1,
"Branched chain amino acids":1,
"cardiometabolic disease":1,
"differentiated thyroid carcinoma":2,
"hypothyroidism":3,
"thyroid-stimulating hormone":2,
"calcitonin":1,
"levothyroxine":1,
"medullary thyroid carcinoma":2,
"multiple endocrine neoplasia":1,
"nausea":1,
"octreotide":1,
"small cell variant":1,
"vomiting":1,
"Computer-assisted":1,
"Deep learning":1,
"Diagnostic imaging":1,
"children":1,
"prognostic factors":1,
"stages":1,
"thyroglobulin":2,
"capsular invasion":1,
"extrathyroid metastases":1,
"urinary iodine concentration":1,
"water iodine":1,
"Hodgkin lymphoma":1,
"colorectal cancer":1,
"consanguinity":1,
"leukemia":1,
"papillary carcinoma":2,
"prostate cancer":1,
"radiation":2,
"central lymph node":1,
"lateral lymph node":1,
"risk factor":1,
"sporadic medullary thyroid carcinoma":1,
"Hot thyroid nodule":1,
"Resection":1,
"Thermal ablation":1,
"NTCP":1,
"dose–response relationship":1,
"oropharyngeal cancer":1,
"patient reported outcome measures":1,
"probability":1,
"radiation injuries":1,
"angiopoietin-like 1":1,
"recurrence":1,
"Intensity-modulated radiotherapy":1,
"Nasopharyngeal carcinoma":1,
"Second primary cancer":1,
"Survival":2,
"Survivorship":1,
"KRAS":1,
"NRAS":1,
"TERT":1,
"and EIF1AX mutations":1,
"BRAF":1,
"diagnostic accuracy":1,
"optimized algorithm":1,
"reproducibility":1,
"shear-wave elastography":1,
"Clinical predictors":1,
"Recurrent PTC":1,
"Thyroid bed":1,
"Thyroid cytology":2,
"ATC":1,
"HES":1,
"HEY":1,
"RBP":1,
"genetically engineered mice":1,
"BRAF V600E mutation":1,
"TERT mutation":1,
"paediatric and young adult":1,
"Lymphatic metastasis":2,
"Neck dissection":3,
"Thyroid imaging":1,
"Thyroid incidentaloma":1,
"Incidentaloma":1,
"Nodule":1,
"Diffuse thyroid disease":1,
"Thyroid imaging reporting and data system":2,
"Thyroiditis":1,
"CT":1,
"MR imaging":1,
"Surgical implications":1,
"Core biopsy":1,
"Fine needle":1,
"Sonography":1,
"NTRK":1,
"cytomorphology":2,
"histology":2,
"kinase":1,
"borderline tumors":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":2,
"Cervical lymphadenopathy":1,
"Computed tomography":2,
"Human papillomavirus":1,
"Tuberculosis":1,
"Adrenal gland":1,
"Extrapulmonary small cell carcinoma":1,
"Genitourinary small cell carcinoma":1,
"Small cell neuroendocrine carcinoma":1,
"adrenocortical carcinoma, ACC":1,
"extrapulmonary small cell carcinoma, EPSCC":1,
"genitourinary, GU":1,
"inferior vena cava, IVC":1,
"small cell carcinoma, SCC":1,
"small cell lung cancer, SCLC":1,
"thyroid transcription factor-1, TTF-1)":1,
"cancer recurrence":1,
"mortality":1,
"AUY922":1,
"BIIB021":1,
"Bim":1,
"HSP90 inhibitor":1,
"SNX5422":1,
"PI3K/Akt/mTOR":1,
"genetic variation":1,
"non-medullary thyroid cancer":1,
"susceptibility":1,
"DLX6-AAS1":1,
"molecular mechanisms":1,
"therapeutic target":1,
"Digital pathology":1,
"Fine-needle biopsy":1,
"Thyroid scintigraphy":1,
"Convolutional neural network":1,
"Level set method":1,
"Thyroid follicular neoplasm":1,
"Ultrasound image":1,
"Hamartoma syndrome, multiple":1,
"PTEN Phosphohydrolase":1,
"germ-line mutation":1,
"neoplasms":2,
"neoplastic syndromes, hereditary":1,
"risk":2,
"Nomogram":1,
"SEER database":1,
"bone":1,
"risk factors":1,
"Insulin-like growth factors":1,
"Carcinoma, acinar cell":1,
"Salivary gland neoplasms":1,
"drug resistance":1,
"non-coding RNA":1,
"Cancer-associated fibroblasts":1,
"Paracrine communication":1,
"dental hard tissue":1,
"oral disease":1,
"radioiodine therapy":1,
"RET":1,
"clinical management":1,
"variants of uncertain significance":1,
"Neuroendocrine tumor":1,
"epiglottis":1,
"lung":1,
"neoplasm":1,
"neuroendocrine":1,
"second primary":1,
"Axillary metastasis":1,
"Surgical treatment":1,
"Bioinformatics analysis":1,
"Platelet RNA-seq":1,
"SVM algorithm":1,
"pediatric differentiated thyroid cancer":1,
"Adenocarcinoma of lung":1,
"EGFR mutation":1,
"Liquid-based cytology":1,
"Thyroid metastasis":2,
"Image-Pro Plus":1,
"virtual touch tissue image":1,
"Chronic lymphocytic thyroiditis":1,
"Lymph node metastasis":1,
"Cáncer de tiroides":1,
"Familial":1,
"Familiar":1,
"Genetics":1,
"Genética":1,
"Germline mutations":1,
"Mutaciones germinales":1,
"No medular":1,
"Non-medullary":1,
"Metastatic thyroid cancer":1,
"Thyroid cancer survival":1,
"Well differentiated thyroid cancer":1,
"Genetic polymorphism":1,
"nitric oxide":1,
"thyroid gland neoplasms":1,
"Morocco":1,
"breast":1,
"genetic predisposition to disease":1,
"genetic variants":1,
"131I":1,
"Dialysis":1,
"Endocrine":1,
"Oncology: Endocrine":1,
"Quality Assurance":1,
"Radiation Safety":1,
"Radionuclide Therapy":1,
"Competitive assay":1,
"LC-MS/MS":1,
"Thyroglobulin antibodies and thyroid cancer":1,
"Bone tumor":1,
"Fibrous dysplasia":1,
"Malignancies":1,
"McCune-Albright syndrome":1,
"fine-needle aspiration (FNA)":1,
"paraganglioma":1,
"sclerosing paraganglioma":1,
"endocrine system tumors":1,
"m6A methylation regulators":1,
"pan-cancer analysis":1,
"risk score":1,
"BRAF V600E":1,
"CRISPR/Cas9":1,
"LIMD2":1,
"epithelial-to-mesenchymal transition":1,
"2-stage":1,
"Double-island flap":1,
"Pedicled thoracoacromial artery perforator flap":1,
"Tracheal reconstruction":1,
"BRAFV600E + TERT":1,
"coexistent genetic mutations":1,
"histopathological features":1,
"HPV related head and neck cancer":1,
"cervical adenopathy with unknown primary":1,
"imaging head and neck cancer":1,
"molecular diagnoses occult primary":1,
"non-HPV related head and neck cancer":1,
"transoral laser microlaryngoscopy (TLM)":1,
"transoral robotic surgery (TORS)":1,
"upper aerodigestive tract cancers":1,
"thyroid gland":1,
"GTEx":1,
"TC2N":1,
"TCGA":1,
"Tac2-N":1,
"Cell migration":1,
"Cell proliferation":1,
"Medullary thyroid cancer":1,
"Somatostatin":1,
"core needle biopsy":1,
"specimen satisfaction":1,
"ectopic thymus":1,
"metastatic lymph nodes":1,
"shear wave sonoelastography":1,
"strain elastography":1,
"gold nanoparticles (AuNPs)":1,
"magnetic nanoparticles (FeNPs)":1,
"molecular target":1,
"protein corona (PC)":1,
"silver nanoparticles (AgNPs)":1,
"FDG PET/CT":1,
"Hürthle cell":1,
"Carcinome papillaire":1,
"Hobnail variant":1,
"Métastases":1,
"Poor outcomes":1,
"Pronostic péjoratif":1,
"Thyroïde":1,
"Variante à cellules en clous de tapissier":1,
"T lymphocyte":1,
"innate immune cells":1,
"Collision tumor":1,
"follicular thyroid carcinoma":1,
"Acromegaly":1,
"Bone resorption":1,
"CTscan, Computed Tomography scan":1,
"Delayed diagnosis":1,
"TSH, Thyroid Stimulating Hormone":1,
"WHO, World Health Organization":1,
"AAF":1,
"Adenoma folicular":1,
"Bethesda IV":1,
"Carcinoma folicular":1,
"Ecografía":1,
"Follicular adenoma":1,
"Follicular carcinoma":1,
"Nódulo tiroideo":1,
"Tipo IV de Bethesda":1,
"Oligometastasis":1,
"small cell lung cancer":1,
"IGFLR1":1,
"kidney clear cell carcinoma":1,
"myeloid derived suppressor cell":1,
"prognosis biomarker":1,
"tumor-infiltrating":1,
"NKT cells":1,
"dendritic cells":1,
"lymphocytes":1,
"monocytes":1,
"natural killer (NK) cells":1,
"thyroid-stimulating hormone (TSH)":1,
"completion thyroidectomy":1,
"lobectomy":1,
"submental approach":1,
"transoral":1,
"vestibular approach":1,
"postoperative":1,
"sinus bradycardia":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年11月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
